AstraZeneca Plc - Proyeksi bathi mangsa ngarep AZN

The visual snapshot of price action on GURU.Markets helps assess the resilience of AstraZeneca PLC (AZN) to regulatory pricing pressure and patent disputes. Meanwhile, the company is implementing eco-friendly inhalers to achieve carbon neutrality by 2030. Profit growth, which stands at 17.62, is driven by the acquisition of biotech startups and new medications for the treatment of cancer and heart disease.

AstraZeneca PLC (AZN): Bathi resik sing dikarepake saka 04.07.2022 nganti 14.11.2026

Rincian analitis perusahaan AstraZeneca Plc (AZN)

- kuotasi lan prakiraan analis:

Kutipan saham AstraZeneca PLC|AZN - Konsensus nilai wajar

- rincian nilai pasar emiten:

Kapitalisasi pasar AstraZeneca|AZN - Nilai Dipunlarasaken Utang lan Kas

- indikator kapitalisasi buku:

Aset Bersih saben Siji Saham AstraZeneca|AZN - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku astrazeneca.com|AZN - Aset Agregat Perusahaan

- indikator total utang lan likuiditas perusahaan:

Total Utang marang Modal AstraZeneca PLC|AZN - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal AstraZeneca AB|AZN - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku AstraZeneca|AZN - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan AstraZeneca|Rasio cepet astrazeneca.com

- data bathi resik lan rasio valuasi:

AZN - Bathi resik|Bathi sing dikarepake AstraZeneca PLC|AZN - Periode bali modal bisnis|Prakiraan rega marang bathi AstraZeneca|AZN - Rasio nilai perusahaan marang wutah bathi|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan AstraZeneca|AZN - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) AstraZeneca|AZN - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan astrazeneca.com|AZN - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep AstraZeneca PLC

- data total pendapatan lan volume dodolan:

AZN - Total pendapatan perusahaan|Prakiraan pendapatan perusahaan AstraZeneca PLC|AZN - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S AstraZeneca

Analisis wiwitan perusahaan:AZN, AstraZeneca PLC

To protect capital from market volatility, investors must evaluate future profit generation potential rather than past reports. Under the leadership of Pascal Soriot, the development of the AstraZeneca PLC (AZN) oncology portfolio ensures business resilience, which is reflected in the company's target profit dynamics; this indicator smooths out currency fluctuations and market noise, revealing the real margin of safety and hidden risks of margin compression.

Perusahaan pesaing